96 related articles for article (PubMed ID: 3393507)
1. [Nonsteroidal antiandrogen inhibition of testosterone metabolism in the prostate].
Reznikov AG; Korpacheva TI
Probl Endokrinol (Mosk); 1988; 34(2):64-7. PubMed ID: 3393507
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroid antiandrogen inhibiting effect on testosterone metabolism in rat prostate and liver.
Reznikov A; Korpacheva T
Endocrinol Exp; 1990 Dec; 24(4):437-47. PubMed ID: 2096078
[TBL] [Abstract][Full Text] [Related]
3. [Effects of cytokine-like polypeptide EMAP II and flutamide on the testosterone-stimulated prostate of castrated rats].
Reznikov OH; Chaĭkovs'ka LV; Poliakova LI; Sachyns'ka OV
Fiziol Zh (1994); 2011; 57(4):12-20. PubMed ID: 22164405
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of protein kinase C isoenzymes in rat ventral prostate: effects of age, castration and flutamide treatment.
Montalvo L; Sánchez-Chapado M; Prieto JC; Carmena MJ
Life Sci; 2002 Sep; 71(19):2257-66. PubMed ID: 12215373
[TBL] [Abstract][Full Text] [Related]
6. [Androgen formation in the testes of hypophysectomized rats exposed to the antiandrogen niftolid (flutamide)].
Volkova NN
Probl Endokrinol (Mosk); 1982; 28(3):76-8. PubMed ID: 7100132
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the accelerative effects of testosterone on hamster facial nerve regeneration by the antiandrogen flutamide.
Kujawa KA; Tanzer L; Jones KJ
Exp Neurol; 1995 Jun; 133(2):138-43. PubMed ID: 7649220
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antiandrogens in the rat.
Burton S; Trachtenberg J
J Urol; 1986 Oct; 136(4):932-5. PubMed ID: 3761464
[TBL] [Abstract][Full Text] [Related]
10. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
[TBL] [Abstract][Full Text] [Related]
11. Androgens regulate brain aromatase activity in adult male rats through a receptor mechanism.
Roselli CE; Resko JA
Endocrinology; 1984 Jun; 114(6):2183-9. PubMed ID: 6723579
[TBL] [Abstract][Full Text] [Related]
12. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Waltregny D; Leav I; Signoretti S; Soung P; Lin D; Merk F; Adams JY; Bhattacharya N; Cirenei N; Loda M
Mol Endocrinol; 2001 May; 15(5):765-82. PubMed ID: 11328857
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
14. Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate.
Kondo Y; Homma Y; Aso Y; Kawabe K; Mieda M; Takahashi H
Prostate; 1996 Sep; 29(3):146-52. PubMed ID: 8827082
[TBL] [Abstract][Full Text] [Related]
15. [Anti-androgenic activity of various substituted carboxyanilides].
Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA
Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597
[TBL] [Abstract][Full Text] [Related]
16. [The effects of antiprostatic agents on the accessory sex organs of rats treated with adrenal androgens].
Imai K; Takahashi O; Watanabe K; Nakazawa Y; Nakata S; Yamanaka H
Hinyokika Kiyo; 1991 Dec; 37(12):1669-76. PubMed ID: 1785391
[TBL] [Abstract][Full Text] [Related]
17. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
18. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited rats.
Nellemann C; Lefevre PA; Ashby J
Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):344-54. PubMed ID: 14666997
[TBL] [Abstract][Full Text] [Related]
20. Postnatal exposure to flutamide affects CDH1 and CTNNB1 gene expression in adult pig epididymis and prostate and alters metabolism of testosterone.
Gorowska E; Zarzycka M; Chojnacka K; Bilinska B; Hejmej A
Andrology; 2014 Mar; 2(2):186-97. PubMed ID: 24353261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
